Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Kala Pharmaceuticals
company
Investors
Number of Lead Investors
Number of Investors
5
15
Kala Pharmaceuticals is funded by 15 investors.
Oxford Finance LLC
and Athyrium Capital Management LP
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Debt |
Athyrium Capital Management LP
|
Yes | Post-IPO Equity |
Longitude Capital
|
Yes | Series C |
Ysios Capital
|
Yes | Series B |
CAM Capital
|
- | Series C |
Lux Capital
|
- | Series C |
OrbiMed
|
- | Series C |
Polaris Partners
|
- | Series C |
RA Capital Management
|
- | Series C |
Vivo Capital
|
- | Series C |
Wellington Management
|
- | Series C |
AbbVie Biotech Ventures
|
- | Series B |
Crown Venture Fund
|
- | Series B |
|
|
- | Series B |
Lighthouse Capital Partners
|
- | Private Equity（PE） |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
